Altamira Therapeutics
Altamira Therapeutics is dedicated to developing RNA-based therapeutics for extrahepatic targets.
Market cap
$390k
Enterprise value
$390k
Share price
$0.05 2RA1.F
Company register number
CH-270.3.015.032-0
Authorizing premium user...